Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Orasure Tech Inc (OSUR)

Orasure Tech Inc (OSUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 310,628
  • Shares Outstanding, K 73,959
  • Annual Sales, $ 405,470 K
  • Annual Income, $ 53,660 K
  • 60-Month Beta 0.09
  • Price/Sales 0.77
  • Price/Cash Flow 3.16
  • Price/Book 0.76
Trade OSUR with:

Options Overview Details

View History
  • Implied Volatility 291.86% ( -76.93%)
  • Historical Volatility 45.84%
  • IV Percentile 99%
  • IV Rank 78.44%
  • IV High 368.79% on 07/18/24
  • IV Low 11.91% on 05/13/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 29
  • Volume Avg (30-Day) 25
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 1,062
  • Open Int (30-Day) 986

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.00
  • Number of Estimates 2
  • High Estimate 0.00
  • Low Estimate 0.00
  • Prior Year -0.07
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.91 +7.28%
on 07/05/24
4.66 -9.87%
on 06/21/24
-0.05 (-1.18%)
since 06/18/24
3-Month
3.91 +7.28%
on 07/05/24
5.59 -24.87%
on 05/06/24
-1.08 (-20.45%)
since 04/19/24
52-Week
3.91 +7.28%
on 07/05/24
8.45 -50.30%
on 01/04/24
-0.34 (-7.49%)
since 07/19/23

Most Recent Stories

More News
OraSure: Q4 Earnings Snapshot

OraSure: Q4 Earnings Snapshot

OSUR : 4.20 (-0.94%)
OraSure: Q3 Earnings Snapshot

OraSure: Q3 Earnings Snapshot

OSUR : 4.20 (-0.94%)
OraSure: Q2 Earnings Snapshot

OraSure: Q2 Earnings Snapshot

OSUR : 4.20 (-0.94%)
OraSure: Q1 Earnings Snapshot

OraSure: Q1 Earnings Snapshot

OSUR : 4.20 (-0.94%)
Why OraSure Technologies Stock Is Jumping Today

Investors applauded the diagnostics company's Q4 update.

OSUR : 4.20 (-0.94%)
OraSure: Q4 Earnings Snapshot

OraSure: Q4 Earnings Snapshot

OSUR : 4.20 (-0.94%)
OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year

InteliSwab® revenue of $43.1 million in Q2, up 95% sequentially with significant scaling in production InteliSwab® gross margins improve sequentially...

OSUR : 4.20 (-0.94%)
OraSure Technologies to Hold 2022 Second Quarter Earnings Conference Call Tuesday, August 9, 2022, 5:00 p.m. ET

BETHLEHEM, Pa., Aug. 02, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering...

OSUR : 4.20 (-0.94%)
OraSure’s Ongoing Commitment to End the Hepatitis C Epidemic Heats Up at the Racetrack

Race to End Hep C initiative demonstrates the ability of easy-to-administer, low-cost testing solutions to identify patients and direct them to...

OSUR : 4.20 (-0.94%)
OraSure Technologies Launches New Product for Microbiome Researchers to Study DNA and RNA

BETHLEHEM, Pa., July 14, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing...

OSUR : 4.20 (-0.94%)

Business Summary

OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well...

See More

Key Turning Points

3rd Resistance Point 4.37
2nd Resistance Point 4.31
1st Resistance Point 4.26
Last Price 4.20
1st Support Level 4.15
2nd Support Level 4.09
3rd Support Level 4.04

See More

52-Week High 8.45
Fibonacci 61.8% 6.72
Fibonacci 50% 6.18
Fibonacci 38.2% 5.65
Last Price 4.20
52-Week Low 3.91

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar